Tamoghna Chattopadhyay

Mr. Tamoghna Chattopadhyay


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2024 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
SOSaket S. Ozarkar
Saket S. Ozarkar
KBKetaki Buwa
Ketaki Buwa
NJNeha Ann Joshy
Neha Ann Joshy
DKDheeraj Komandur
Dheeraj Komandur
PTPaul M. Thompson
Paul M. Thompson
Abnormal β-amyloid (Aβ) accumulation in the brain is an early indicator of Alzheimer’s disease (AD) and is typically assessed through invasive procedures such as PET (positron emission tomography) or CSF (cerebrospinal fluid) assays. As new anti-Alzheimer’s treatments can now successfully target amyloid pathology, there is a growing interest in predicting Aβ positivity (Aβ+) from less invasive, more widely available types of brain scans, such as T1-weighted (T1w) MRI. Here we compare multiple approaches to infer Aβ + from standard anatomical MRI: (1) classical machine learning algorithms, including logistic regression, XGBoost, and shallow artificial neural networks, (2) deep learning models based on 2D and 3D convolutional neural networks (CNNs), (3) a hybrid ANN-CNN, combining the strengths of shallow and deep neural networks, (4) transfer learning models based on CNNs, and (5) 3D Vision Transformers. All models were trained on paired MRI/PET data from 1,847 elderly participants (mean age: 75.1 yrs. ± 7.6SD; 863 females/984 males; 661 healthy controls, 889 with mild cognitive impairment (MCI), and 297 with Dementia), scanned as part of the Alzheimer’s Disease Neuroimaging Initiative. We evaluated each model’s balanced accuracy and F1 scores. While further tests on more diverse data are warranted, deep learning models trained on standard MRI showed promise for estimating Aβ + status, at least in people with MCI. This may offer a potential screening option before resorting to more invasive procedures.

16 February 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
SOSaket S. Ozarkar
Saket S. Ozarkar
KBKetaki Buwa
Ketaki Buwa
STSophia I. Thomopoulos
Sophia I. Thomopoulos
PTPaul M. Thompson
Paul M. Thompson
TIThe Alzheimer’s Disease Neuroimaging Initiative
The Alzheimer’s Disease Neuroimaging Initiative
Abnormal β-amyloid (Aβ) accumulation in the brain is an early indicator of Alzheimer’s disease and practical tests could help identify patients who could respond to treatment, now that promising anti-amyloid drugs are available. Even so, Aβ positivity (Aβ+) is assessed using PET or CSF assays, both highly invasive procedures. Here, we investigate how well Aβ+ can be predicted from T1 weighted brain MRI and gray matter, white matter and cerebrospinal fluid segmentations from T1-weighted brain MRI (T1w), a less invasive alternative. We used 3D convolutional neural networks to predict Aβ+ based on 3D brain MRI data, from 762 elderly subjects (mean age: 75.1 yrs. ±7.6SD; 394F/368M; 459 healthy controls, 67 with MCI and 236 with dementia) scanned as part of the Alzheimer’s Disease Neuroimaging Initiative. We also tested whether the accuracy increases when using transfer learning from the larger UK Biobank dataset. Overall, the 3D CNN predicted Aβ+ with 76% balanced accuracy from T1w scans. The closest performance to this was using white matter maps alone when the model was pre-trained on an age prediction in the UK Biobank. The performance of individual tissue maps was less than the T1w, but transfer learning helped increase the accuracy. Although tests on more diverse data are warranted, deep learned models from standard MRI show initial promise for Aβ+ estimation, before considering more invasive procedures. Clinical Relevance: Early detection of Aβ positivity from less invasive MRI images, could offer a screening test prior to more invasive testing procedures.

4 February 2026 in Frontiers in Neuroimaging
Verified
Journal Article
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
PSPavithra Senthilkumar
Pavithra Senthilkumar
RARahul H. Ankarath
Rahul H. Ankarath
CPChristopher Patterson
Christopher Patterson
EGEmma J. Gleave
Emma J. Gleave
PTPaul M. Thompson
Paul M. Thompson
Predicting the trajectory of clinical decline in aging individuals is a pressing challenge, especially for people with mild cognitive impairment, Alzheimer’s disease, Parkinson’s disease, or vascular dementia. Accurate predictions can guide treatment decisions, identify risk factors, and optimize clinical trials. In this study, we compared two deep learning approaches for forecasting changes, over a 2-year interval, in the Clinical Dementia Rating scale ‘sum of boxes’ score (sobCDR), as a continuous outcome (regression). This is a key metric in dementia research and clinical trials, and scores range from 0 (no impairment) to 18 (severe impairment). To predict decline, we trained a hybrid convolutional neural network (CNN) that integrates 3D T1-weighted brain MRI scans with tabular clinical and demographic features (including age, sex, body mass index (BMI), and baseline sobCDR). We benchmarked its performance against AutoGluon, an automated multimodal machine learning framework that selects an appropriate neural network architecture (an ‘autoML’ approach). We evaluated the models using data from 2,319 unique participants drawn from three independent cohorts—ADNI, OASIS-3, and NACC. For each participant, we used one T1-weighted brain MRI scan along with corresponding clinical and demographic information. Our results demonstrate the importance of combining image and tabular data in predictive modeling for this clinical application. Deep learning algorithms can fuse information from image-based brain signatures and tabular clinical data, with potential for personalized prognostics in aging and dementia. Rather than concluding that multimodal fusion uniformly improves performance, our results show that deep learning applied to volumetric MRI data may struggle to add predictive value, particularly when clinical covariates explain substantial variance and provide a strong baseline. In other conditions and tasks, it may help to have a hybrid system that can learn from both data types, and their relative value may be different. Conversely, AutoML-based multimodal fusion provides a robust baseline when tabular data already provide strong predictive value for the task. These insights clarify how different multimodal strategies could be selected in clinical prognostic applications.

1 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
ASAmit Singh
Amit Singh
ELEmily Laltoo
Emily Laltoo
CBChristina P. Boyle
Christina P. Boyle
COConor Owens-Walton
Conor Owens-Walton
PTPaul M. Thompson
Paul M. Thompson
Parkinson’s disease (PD) is a progressive neurodegenerative disease that affects over 10 million people worldwide. Brain atrophy and microstructural abnormalities tend to be more subtle in PD than in other age-related conditions such as Alzheimer’s disease, so there is interest in how well machine learning methods can detect PD in radiological scans. Deep learning models based on convolutional neural networks (CNNs) can automatically distil diagnostically useful features from raw MRI scans, but most CNN-based deep learning models have only been tested on T1-weighted brain MRI. Here we examine the added value of diffusion-weighted MRI (dMRI) - a variant of MRI, sensitive to microstructural tissue properties - as an additional input in CNN-based models for PD classification. Our evaluations used data from 3 separate cohorts - from Chang Gung University, the University of Pennsylvania, and the PPMI dataset. We trained CNNs on various combinations of these cohorts to find the best predictive model. Although tests on more diverse data are warranted, deep-learned models from dMRI show promise for PD classification. Clinical Relevance This study supports the use of diffusion-weighted images as an alternative to anatomical images for AI-based detection of Parkinson’s disease.

7 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
SOSaket S. Ozarkar
Saket S. Ozarkar
CJChirag Jagad
Chirag Jagad
NJNeha A Joshy
Neha A Joshy
KBKetaki S. Buwa
Ketaki S. Buwa
VDVraj Dharmesh Desai
Vraj Dharmesh Desai
Generative AI models, such as Stable Diffusion, DALL-E, and MidJourney, have recently gained widespread attention as they can generate high-quality synthetic images by learning the distribution of complex, high-dimensional image data. These models are now being adapted for medical and neuroimaging data, where AI-based tasks such as diagnostic classification and predictive modeling typically use deep learning methods, such as convolutional neural networks (CNNs) and vision transformers (ViTs), with interpretability enhancements. In our study, we trained latent diffusion models (LDM) and denoising diffusion probabilistic models (DDPM) specifically to generate synthetic diffusion tensor imaging (DTI) maps. We developed models that generate synthetic DTI maps of mean diffusivity by training on real 3D DTI scans, and evaluating realism and diversity of the synthetic data using maximum mean discrepancy (MMD) and multi-scale structural similarity index (MS-SSIM). We also assess the performance of a 3D CNN-based sex classifier, by training on combinations of real and synthetic DTIs, to check if performance improved when adding the synthetic scans during training, as a form of data augmentation. Our approach efficiently produces realistic and diverse synthetic data, potentially helping to create interpretable AI-driven maps for neuroscience research and clinical diagnostics.

25 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
TCTamoghna Chattopadhyay
Tamoghna Chattopadhyay
CJChirag Jagad
Chirag Jagad
RKRudransh Kush
Rudransh Kush
VDVraj Dharmesh Desai
Vraj Dharmesh Desai
STSophia I. Thomopoulos
Sophia I. Thomopoulos
PTPaul M. Thompson
Paul M. Thompson
Diffusion tensor imaging (DTI) is a key neuroimaging modality for assessing brain tissue microstructure, yet high-quality acquisitions are costly, time-intensive, and prone to artifacts. To address data scarcity and privacy concerns – and to augment the available data for training deep learning methods – synthetic DTI generation has gained interest. Specifically, denoising diffusion probabilistic models (DDPMs) have emerged as a promising approach due to their superior fidelity, diversity, controllability, and stability compared to generative adversarial networks (GANs) and variational autoencoders (VAEs). In this work, we evaluate the quality, fidelity and added value for downstream applications of synthetic DTI mean diffusivity (MD) maps generated by 2D slice-wise and 3D volume-wise DDPMs. We evaluate their computational efficiency and utility for data augmentation in two downstream tasks: sex classification and dementia classification using 2D and 3D convolutional neural networks (CNNs). Our findings show that 3D synthesis outperforms 2D slice-wise generation in downstream tasks. We present a benchmark analysis of synthetic diffusion-weighted imaging approaches, highlighting key trade-offs in image quality, diversity, efficiency, and downstream performance.